학술논문

The therapeutic CD38 monoclonal antibody daratumumab induces programmed cell death via fcg receptor-mediated cross-linking
Document Type
Article
Source
In: Journal of Immunology. (Journal of Immunology, 1 August 2016, 197(3):807-813)
Subject
Language
English
ISSN
15506606
00221767